about
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Two distinct metacommunities characterize the gut microbiota in Crohn's disease patients.Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.Modifiable Environmental Factors in Inflammatory Bowel Disease.The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli.Management of patients with inflammatory bowel disease and spondyloarthritis.Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response.miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn's DiseaseOral manifestations as the first presenting sign of Crohn's disease in a pediatric patient.Ophthalmic manifestations in patients with inflammatory bowel disease: A reviewAnti-NKG2D mAb: A New Treatment for Crohn's Disease?Can We Predict the Efficacy of Anti-TNF-α Agents?A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.Effect of Electro-Acupuncture and Moxibustion on Brain Connectivity in Patients with Crohn's Disease: A Resting-State fMRI Study.TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice.Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.Transcriptional decomposition reveals active chromatin architectures and cell specific regulatory interactions.Familial and ethnic risk in inflammatory bowel disease.Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.Efficacy of vedolizumab in fistulising Crohn's disease: Exploratory analyses of data from GEMINI 2.A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease.Macrophage Depletion Protects against Cigarette Smoke-Induced Inflammatory Response in the Mouse Colon and Lung.Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish PopulationUsefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
P2860
Q33819478-4539E123-89F3-474B-9787-9E5CCB7CD7AAQ38706536-352336FA-455A-4144-BF05-73617B5AF9E2Q38726458-9F12B714-3A8A-4DD5-8754-F2822A91FAFAQ38748380-C16C420E-1CE4-4BF4-84BD-EB0483154310Q38843247-726593F5-84AB-4182-9432-C5B247C7CFF9Q39443996-769D857C-044C-4C77-AA2C-AF1E8F5ADBFCQ40044097-FD07BD06-7925-4F18-ADE3-BABF3E24C466Q40054186-3BFB3D45-1DC3-48C5-BBC6-7DC5FDAFED6CQ40116327-D6B44C65-BE10-47B7-A5CA-FAD6EF043CB4Q41221440-BC8A6C90-F4E6-4CE4-8364-FAC4F4C72BACQ41321802-8D3780C1-2EAF-46AE-80BD-66C7C60B4C2FQ41608459-4A87D8B6-1A94-400D-8670-2B62303D270DQ41660377-84E53ABB-7958-4AE8-9E83-322CC2CA52D6Q41660559-C57584BE-1C5F-4B4A-AC14-98FF07444C74Q42369594-34B5991E-D33F-479B-A967-BB0C241B9F6DQ46273136-07A9BF57-15C3-4101-A6E1-8CCA23D38C6FQ47567635-DAA67AE3-7108-4547-9116-6256F3BB8E89Q47725450-D1BD11F9-808F-455B-BAF9-B77F2F20EF55Q48099475-44F808E4-8EB1-4DA9-BB6D-8F237F008AC5Q48103472-8AF14748-DC91-475F-9533-4F796E3C9E54Q49166608-16B6FE79-B507-4825-8F39-4F6078F513EFQ49387112-6D026F19-48AB-499D-996D-57F05247A0A0Q50093819-6AD4CA9D-4499-48DF-9070-F6236EF94858Q50578123-0DDF4FD8-18E7-437A-A597-5C722F37B29EQ51748809-84CD6A9C-EFDB-4EFF-80A0-6A88FCA2C01FQ52568296-347CD30E-73E4-4120-9FDD-628063BD23B9Q52595779-31C0177A-0F66-4B54-A1FB-F77A6BB0C7AFQ52716602-D152A4FE-2222-4518-A492-715D6701CB28Q53718821-DFAEAFBE-AC13-4752-8592-C119B7BA6905Q55127187-E539FF8F-97EB-4FEE-B875-F83380177420Q55693561-1D50E3D6-F16D-4C13-931C-703902F031CCQ57161637-3F1B31CD-94ED-4600-A2DA-6DFEAAC8A509Q57284254-B779A2D3-2827-498E-A593-D4FD7AF88833
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Crohn's disease.
@ast
Crohn's disease.
@en
type
label
Crohn's disease.
@ast
Crohn's disease.
@en
prefLabel
Crohn's disease.
@ast
Crohn's disease.
@en
P1433
P1476
Crohn's disease.
@en
P2093
Joana Torres
Saurabh Mehandru
P304
P356
10.1016/S0140-6736(16)31711-1
P407
P577
2016-11-30T00:00:00Z